Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair changes during Wegovy treatment are real, but they are almost always temporary and tied to rapid weight loss rather than the medicine itself. The condition — telogen effluvium — typically begins two to four months after significant calorie restriction starts, and most people see regrowth within six to twelve months without stopping treatment. These are prescription-only medicines, and a prescriber reviews your full picture before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the question our prescribers hear most weeks, and it is worth addressing head-on: the evidence does not point to semaglutide acting on hair follicles directly. What clinical reports and trial data consistently show is that hair shedding during Wegovy treatment follows the same pattern as any period of significant, rapid weight loss, whether through medicine, surgery, or aggressive calorie restriction.
The NHS notes that hair loss can occur as a side effect of semaglutide, and this is documented in the NHS medicines page on semaglutide. But the mechanism matters. The body responds to rapid physiological change by shifting a larger-than-usual proportion of hair follicles into the resting (telogen) phase simultaneously. Two to four months later, those follicles shed together, which is why the shedding seems to arrive out of nowhere.
It looks alarming. Handfuls in the shower, more on the pillow. The reassuring part is that the follicles themselves are not destroyed. They cycle through and, for most people, grow back normally. Stopping Wegovy is rarely necessary for this reason alone, and doing so without clinical guidance could interrupt progress that took months to achieve. If you have questions about your specific situation, our semaglutide overview covers the broader treatment picture, and our team is there to talk it through.
Telogen effluvium is not a disease. It is a temporary shift in the hair growth cycle triggered by physiological stress, surgery, illness, nutritional change, or in this context, sustained calorie deficit. Under normal circumstances roughly 85–90% of scalp follicles are in the growth (anagen) phase at any one time. A stressor nudges an abnormally large cohort into the resting phase early.
After the resting phase (which lasts roughly two to three months), those follicles shed in a wave. That wave is what people notice. The good news is that the same follicles then re-enter the growth phase, and new hair emerges over the following months. The shedding itself is the signal that regrowth is already underway at the follicle level.
For people on Wegovy, the stressor is most intense in the first few months of treatment when weight loss is steepest. As the rate of loss moderates and the body adapts, the trigger diminishes. Most people report that shedding slows noticeably by the six-month mark. Our page on losing hair on Wegovy goes into this timeline in more detail, and the pattern around whether hair grows back after semaglutide is addressed separately for people further along in treatment.
There is no single proven intervention that stops telogen effluvium once triggered, but a few practical steps have a reasonable evidence base and cause no harm.
Protein is the most important nutritional factor. Rapid weight loss often involves eating considerably less, and protein (the building block of the hair shaft) can fall short without attention. Adults generally need at least 1.2–1.6 g of protein per kilogram of body weight during active weight loss, though your prescriber or a registered dietitian can give you a figure that fits your situation. Eggs, fish, legumes, Greek yoghurt and lean meat are all practical sources to build meals around.
Iron deficiency is a separate and common cause of hair shedding in women, and it can compound the picture. A simple blood test through your GP can rule it in or out. Zinc and biotin deficiencies are also sometimes implicated, though supplementing these speculatively is rarely useful unless a deficiency is confirmed.
Gentle handling matters more than most people expect: heat styling, tight styles and harsh shampoos all add mechanical stress to already-cycling follicles. None of this is about restricting treatment. It is about supporting your body through a period of rapid change. You can read about the broader experience of hair and Wegovy, and our page on semaglutide and hair covers the shared mechanism across GLP-1 medicines. Cost is occasionally raised as part of the conversation about whether to continue, if that is relevant to you, our Wegovy price guide sets out what UK treatment typically involves.
Telogen effluvium is usually self-limiting and resolves without intervention. But not every hair change during treatment is telogen effluvium, and it is worth knowing what would prompt a conversation with a clinician sooner rather than later.
Patchy hair loss (rather than diffuse shedding) can indicate alopecia areata, an autoimmune condition unrelated to weight-loss treatment. Shedding that continues beyond twelve months without any regrowth signal, or that is accompanied by changes in the scalp itself, warrants investigation. Thyroid disorders, which affect both weight and hair, sometimes surface or worsen during periods of significant weight change; your GP can screen for these with a standard blood panel.
If you are on Wegovy and your hair is bothering you, mention it at your next prescriber review. Do not stop treatment unilaterally. The evidence on hair loss and Wegovy is reassuring for the majority of people, and a clinician can help distinguish normal telogen effluvium from something that needs further investigation.
If you are considering starting semaglutide and want to understand the full treatment picture, including how a same-day clinical review works, you are welcome to speak to our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.